Back to search results

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Lymphocytic Leukemia · Chronic Myeloid Leukemia, BCR-ABL1 Positive · Hematopoietic and Lymphoid System Neoplasm · Hodgkin Lymphoma · Myelodysplastic Syndrome · Myelofibrosis · Myeloproliferative Neoplasm · Non-Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Vaibhav Agrawal) · vagrawal@coh.org · 626-256-4673
    Contact: Principal Investigator (Vaibhav Agrawal)

  • Northside Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Scott R. Solomon, MD) · ssolomon@bmtga.com · 404-255-1930
    Contact: Principal Investigator (Scott R. Solomon)

  • DFCI/BWH Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Lindsey Baden, MD) · lbaden@bwh.harvard.edu · 617-732-6801
    Contact: Principal Investigator (Lindsey Baden, MD)
Study leads

  • Vaibhav Agrawal, MD

    Principal Investigator

    City of Hope Medical Center

View source on ClinicalTrials.gov(opens in a new tab)